I agree that this site is using cookies. You can find further informations here.
X
Mantia-Smaldone, Gina
61  results:
Search for persons X
?
1

Evaluating the impact of epigenetics: Does MLH1 promoter hy..:

Craig, Amaranta ; Huang, Min ; Huelsmann, Erica..
Gynecologic Oncology.  176 (2023)  - p. S82 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Molecular portraits of clear cell ovarian and endometrial c..:

Ackroyd, Sarah A. ; Arguello, David ; Ramos, Pilar...
Gynecologic Oncology.  169 (2023)  - p. 164-171 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Trends in primary treatment of advanced ovarian cancer: A r..:

Craig, Amaranta ; Deng, Mengying ; Handorf, Elizabeth...
Gynecologic Oncology.  166 (2022)  - p. S173 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Genomic profiling in low grade serous ovarian cancer: Ident..:

ElNaggar, Adam ; Robins, David ; Baca, Yasmine...
Gynecologic Oncology.  167 (2022)  2 - p. 306-313 , 2022
Link: https://doi.org/10.1016/..
 
?
5

MIRASOL: A randomized, open-label, phase 3 study of mirvetu..:

Moore, Kathleen ; Konecny, Gottfried ; Martin, Lainie...
Gynecologic Oncology.  166 (2022)  - p. S156-S157 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Molecular analysis of endometrioid and non-endometrioid ute..:

Corey, Logan ; Wu, Sharon ; Mantia-Smaldone, Gina...
Gynecologic Oncology.  166 (2022)  - p. S133-S134 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Outcomes of secondary cytoreductive surgery for patients wi..:

Gockley, Allison ; Melamed, Alexander ; Cronin, Angel...
American Journal of Obstetrics and Gynecology.  221 (2019)  6 - p. 625.e1-625.e14 , 2019
Link: https://doi.org/10.1016/..
 
?
8

A phase 1b dose escalation study of ipafricept (OMP 54F28) ..:

Moore, Kathleen N. ; Gunderson, Camille C. ; Sabbatini, Paul...
Gynecologic Oncology.  154 (2019)  2 - p. 294-301 , 2019
Link: https://doi.org/10.1016/..
 
?
9

A preoperative risk score to predict red blood cell transfu..:

Ackroyd, Sarah A. ; Brown, Jennifer ; Houck, Karen...
American Journal of Obstetrics and Gynecology.  219 (2018)  6 - p. 598.e1-598.e10 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Disparities in the management and outcome of cervical cance..:

Churilla, Thomas ; Egleston, Brian ; Dong, Yanqun...
Gynecologic Oncology.  141 (2016)  3 - p. 516-523 , 2016
Link: https://doi.org/10.1016/..
 
?
11

The immunomodulatory effects of pegylated liposomal doxorub..:

Mantia-Smaldone, Gina ; Ronner, Lukas ; Blair, Anne...
Gynecologic Oncology.  133 (2014)  3 - p. 584-590 , 2014
Link: https://doi.org/10.1016/..
 
?
12

Soluble MUC1 and serum MUC1-specific antibodies are potenti..:

Budiu, Raluca A. ; Mantia-Smaldone, Gina ; Elishaev, Esther...
Cancer Immunology, Immunotherapy.  60 (2011)  7 - p. , 2011
Link: https://doi.org/10.1007/..
 
?
13

Targeted treatment of recurrent platinum-resistant ovarian ..:

Mantia-Smaldone, Gina ; Edwards, Robert ; Vlad, Anda
Cancer Management and Research.  , 2010
Link: https://doi.org/10.2147/..
 
?
14

Conservative Management of Postoperatively Diagnosed Cystot..:

Alperin, Marianna ; Mantia-Smaldone, Gina ; Sagan, Elizabeth R.
Urology.  73 (2009)  5 - p. 1163.e17-1163.e19 , 2009
Link: https://doi.org/10.1016/..
 
?
15

Phase 1b study of mirvetuximab soravtansine, a folate recep..:

Richardson, Debra L. ; Moore, Kathleen N. ; Vergote, Ignace...
Gynecologic Oncology.  185 (2024)  - p. 186-193 , 2024
Link: https://doi.org/10.1016/..
 
1-15